Resources
About Us
Home Report
Store
Nuclear Medicine/ Radio pharmaceuticals and Stable Isotopes Market
Global Nuclear Medicine/Radiopharmaceuticals and Stable Isotopes Market Outlook: 2013-2018
Report ID:MRHC - 104232 Pages: 270 Sep-2013 Formats*: PDF Category: Healthcare Delivery: 2 to 4 HoursRadiopharmacology is the study and preparation of radiopharmaceuticals, which are radioactive pharmaceuticals. Radiopharmaceuticals are used in the field of nuclear medicine as tracers in the diagnosis and treatment of many diseases. Utilization of these molecules for medical purposes in PET and SPECT imaging has changed the entire algorithm of disease diagnosis. With rise in the aging population globally coupled with increasing rate of chronic cardiovascular, oncology and neurology diseases, there is tremendous growth potential in this market, especially in developing nations.
The major driving forces of radiopharmaceuticals market are increasing incidence of cancer and cardiac ailments, increasing use of SPECT and PET scans, rising awareness of radiopharmaceuticals, and ready availability of radiopharmaceuticals from cyclotrons. However, shorter half-life of radiopharmaceuticals and competition from conventional diagnostic procedures are restraints of the market.
The Radiopharmacology market is broadly segmented as diagnostic and therapeutic. Diagnostic market is further classified as SPECT and PET, followed by Thallium-201(Tl-201), Gallium-67 (Ga-67) and Iodine-123 (I-123). SPECT is majorly used in cardiology related diagnosis. The PET radioisotopes market is dominated by Fluoride-18 (F-18), followed by Rubidium-82 (Rb-82), While Therapeutic market is further classified into beta emitters, brachytherapy isotopes, and alpha emitters.
This research report provides comprehensive analysis of radiopharmaceutical market across the globe. The geographical regions covered in this report are North America (U.S, Canada), Europe (Germany, France, Italy, U.K, Spain), Asia- pacific (Japan, India, Chain) and rest of world (Latin America, Middle East Africa).
The research report meticulously analyses the radiopharmaceutical market on the basis of following categories.
Radiopharmaceuticals Market
Diagnostic
 SPECT
 Tc-99m
 Tl-201
 Ga-67
 I-123
 Others
o PET
 F-18
 Rb-82
 Others
• Therapy
o Beta emitters
 I-131
 Sm-153
 Re-186
 Y-90
 Lu-177
 Others
o Alpha emitters
o Brachytherapy
 Cs-131
 I-125
 Pd-103
 Ir-192
 Others
Enriched Stable Isotopes Market
• Deuterium
• Oxygen-18
• Carbon-13
• Nitrogen-15
• Others
Source: Expert Interviews, Government Authorities, Related associations/Institutes, Related Research Publication, Government Publication, Company Press Release, Company Annual Reports, Company Website, Company Publication, SEC Filings, Meticulous Analysis.
Related Tag:
Healthcare
Manufacturing
Quick Contact
Related Reports
Published Date: Sep-2024
Published Date: Sep-2024
Published Date: Apr-2023
Published Date: Nov-2017
Published Date: Jun-2017
